Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.39USD
15 Feb 2019
Change (% chg)

$0.01 (+0.72%)
Prev Close
$1.38
Open
$1.44
Day's High
$1.44
Day's Low
$1.39
Volume
293
Avg. Vol
2,151
52-wk High
$3.64
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.28 -0.098
Jun '18 0.39 -0.075
Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. 9.46 147.79 49.87
P/E Low - Last 5 Yrs. 9.46 47.97 24.25
Beta -0.19 1.08 0.90
Price to Sales (TTM) 13.52 49.51 6.29
Price to Book (MRQ) 8.54 10.14 5.26
Price to Tangible Book (MRQ) 8.54 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 4.64 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -7.80 48.79 5.84
Sales - 5 Yr. Growth Rate -16.73 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -59.84 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 5.16 3.50 3.08
LT Debt to Equity (MRQ) 0.00 18.65 11.38
Total Debt to Equity (MRQ) 0.00 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -110.45 12.86
Operating Margin (TTM) -197.09 -184.67 6.20
Operating Margin - 5 Yr. Avg. -320.58 -126.94 8.31
Pre-Tax Margin (TTM) -253.47 -175.36 7.16
Pre-Tax Margin - 5 Yr. Avg. -264.44 -132.73 8.61
Net Profit Margin (TTM) -253.47 -182.07 3.29
Net Profit Margin - 5 Yr. Avg. -264.44 -137.12 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 7,654,354 842,397,297
Net Income/Employee (TTM) -492,081 562,076 99,842,671
Receivable Turnover (TTM) 4.40 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.19 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 6.39 11.06
Return on Assets - 5 Yr. Avg. -57.32 5.47 12.20
Return on Investment (TTM) -119.26 8.92 14.45
Return on Investment - 5 Yr. Avg. -262.99 6.78 15.87
Return on Equity (TTM) -119.07 10.08 15.96
Return on Equity - 5 Yr. Avg. -367.36 8.32 17.00
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.45%
# of Holders: 23
Total Shares Held: 615,697
3 Mo. Net Change: -62,557
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 9
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.